EDQM: Policy for CEP Applications published for Comments
![Drug Master File Procedures in the EU, the US and Japan - Live Online Training](files/eca/userImages/training.img/Z-ECA-Drug-Master-File-Procedures-LOT.jpg)
Recommendation
17/18 September 2024
With updates on the CEP 2.0!
In June, the draft Certification Policy Document PA/PH/CEP(04) 1, 6R "Content of the dossier for CEP applications for chemical purity and microbiological quality of substances for pharmaceutical use" was published on the EDQM (European Directorate for the Quality of Medicines & HealthCare) website for comments. Comments and remarks on this draft can be submitted until 15 September 2023. Following the consultation period, the final document will be published on the EDQM website.
This draft is intended to provide guidance for applicants for a CEP (Certificate of Suitability). It applies to all substances listed in the European Pharmacopoeia for which the certification procedure is relevant. These are mainly active substances, but excipients described in the monographs may also be included. However, the requirements for excipients may differ from the requirements for active substances.
The draft for comment explains that a new CEP application should contain three modules.
The facts to be included in modules 1-3 are listed and explained in detail in the policy document. In principle, the structure should be as follows:
- Module 1: Cover Letter and Complete Application
- Module 2: Quality Overall Summary
- Module 3: Structure according to the CTD, i.e. analogous to ICH M4.
Related GMP News
17.07.2024EMA: Q&A document for "Centralised Procedures" updated again
16.07.2024CMDh/HMA: New Update of the Q&A List on Variations
18.06.2024EDQM: New Guideline for sterile Substances published for Comment
18.06.2024EMA updates IRIS Guide
02.05.2024EDQM: Updated Information on the Quality Overall Summary (Module 2)
02.05.2024EDQM: Manufacturing Sites in CEP 2.0?